Brief: Valeo Pharma Reports Revenue Up 7% To C$6.1 Mln
Sept 13 (Reuters) - Valeo Pharma Inc VPH.TO :
* VALEO PHARMA REPORTS RECORD THIRD QUARTER 2022 RESULTS AND
HIGHLIGHTS
* VALEO PHARMA INC Q3 REVENUE ROSE 7 PERCENT TO C$6.1
MILLION
* VALEO PHARMA INC SEES Q4 2022 REVENUE MORE THAN C$11.0
MILLION
* VALEO PHARMA INC - NET LOSS OF $4.7 MILLION FOR Q3-22
Source text for Eikon: ID:nCNWd4s88a
Further company coverage: VPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valeo Pharma
See all newsBrief: Valeo Pharma Says Co Initiates Restructuring Proceedings
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada